Strokovne reference:

  1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification of dry eye report, Ocular Surface, 2017;15:276-83; Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology of dry eye report, Ocular Surface 2017;15:438-510.
  2. Shollmayer P, Matovič K. Nove smernice zdravljenja bolezni suhega očesa, Očesna površina/Izbrana poglavja iz oftalmologije, Zbornik Jašetov dan, 2018; 7-24.
  3. Lemp MA, Bron AJ, Baudouin C, Benítez-del-Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151(5):792-8.
  4. Baeyens V, Bron A, Baudouin C. Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease. J Fr Ophtalmol. 2012;35(6):412-9.
  5. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol. 2005;243:531-8.
  6. Rimmer S. An open, non-comparative, exploratory trial on the performance profile of a contact lens lubricant (SVS20) after single instillation in symptomatic contact lens wearers. [Study report]. Cardiff, United Kingdom: Cardiff University; 2000 Jul 26. Report No.: SVS20-98-01.
  7. Monografija izdelkov Vismed, 20 years of experience, TRB Chemedica - Data on File, 2018.